382 related articles for article (PubMed ID: 19380810)
1. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
[TBL] [Abstract][Full Text] [Related]
2. Comment on "Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreER(T2)".
Uhmann A; Dittmann K; Wienands J; Hahn H
J Immunol; 2009 Sep; 183(5):2891; author reply 2891-2. PubMed ID: 19696426
[No Abstract] [Full Text] [Related]
3. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.
Hameyer D; Loonstra A; Eshkind L; Schmitt S; Antunes C; Groen A; Bindels E; Jonkers J; Krimpenfort P; Meuwissen R; Rijswijk L; Bex A; Berns A; Bockamp E
Physiol Genomics; 2007 Sep; 31(1):32-41. PubMed ID: 17456738
[TBL] [Abstract][Full Text] [Related]
4. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
5. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
Jäger R; Maurer J; Jacob A; Schorle H
Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
[TBL] [Abstract][Full Text] [Related]
6. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
7. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
Hayashi S; McMahon AP
Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
[TBL] [Abstract][Full Text] [Related]
8. Inducible gene inactivation in neurons of the adult mouse forebrain.
Erdmann G; Schütz G; Berger S
BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
[TBL] [Abstract][Full Text] [Related]
9. Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies.
Luche H; Weber O; Nageswara Rao T; Blum C; Fehling HJ
Eur J Immunol; 2007 Jan; 37(1):43-53. PubMed ID: 17171761
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice for conditional gene manipulation in astroglial cells.
Slezak M; Göritz C; Niemiec A; Frisén J; Chambon P; Metzger D; Pfrieger FW
Glia; 2007 Nov; 55(15):1565-76. PubMed ID: 17823970
[TBL] [Abstract][Full Text] [Related]
11. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids.
Schmidt EE; Taylor DS; Prigge JR; Barnett S; Capecchi MR
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13702-7. PubMed ID: 11087830
[TBL] [Abstract][Full Text] [Related]
12. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.
Qiu HY; Guo C; Cheng XW; Huang Y; Xiong ZQ; Ding YQ
Genesis; 2008 Jun; 46(6):324-8. PubMed ID: 18543300
[TBL] [Abstract][Full Text] [Related]
13. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
Heidmann D; Lehner CF
Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
[TBL] [Abstract][Full Text] [Related]
15. Generating conditional knockout mice.
Friedel RH; Wurst W; Wefers B; Kühn R
Methods Mol Biol; 2011; 693():205-31. PubMed ID: 21080282
[TBL] [Abstract][Full Text] [Related]
16. Temporally controlled somatic mutagenesis in smooth muscle.
Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
[TBL] [Abstract][Full Text] [Related]
17. A mouse tool for conditional mutagenesis in ovarian granulosa cells.
Grabner B; Blaas L; Musteanu M; Hoffmann T; Birbach A; Eferl R; Casanova E
Genesis; 2010 Oct; 48(10):612-7. PubMed ID: 20715176
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen modulates apoptosis in multiple modes of action in CreER mice.
Takebayashi H; Usui N; Ono K; Ikenaka K
Genesis; 2008 Dec; 46(12):775-81. PubMed ID: 19105217
[TBL] [Abstract][Full Text] [Related]
19. Temporal regulation of Cre recombinase activity in neural stem cells.
Imayoshi I; Ohtsuka T; Metzger D; Chambon P; Kageyama R
Genesis; 2006 May; 44(5):233-8. PubMed ID: 16652364
[TBL] [Abstract][Full Text] [Related]
20. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
